Funds holding DRUGS MADE IN AMERICA ACQUISITION CORP
ISIN KYG2847J1040 · United States
- Fund holders
- 6
- Of which ETFs
- 0 6 other funds
- Value held
- 15.2M $
- Share of capital
- 5.9 % of 24.3M shares on Aug 14, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| First Trust Merger Arbitrage Fund INVESTMENT MANAGERS SERIES TRUST II | 675,366 | 7.2M $ | 0.44 % | 2.78 % | as of Jun 30, 2026 ↗ |
| The Merger Fund Merger Fund | 564,804 | 6M $ | 0.24 % | 2.33 % | as of Jun 30, 2026 ↗ |
| First Trust Multi-Strategy Fund INVESTMENT MANAGERS SERIES TRUST II | 105,083 | 1.1M $ | 0.08 % | 0.43 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 62,273 | 660.1K $ | 0.00 % | 0.26 % | as of May 31, 2026 ↗ |
| JNL Multi-Manager Alternative Fund JNL Series Trust | 10,277 | 109.5K $ | 0.01 % | 0.04 % | as of Jun 30, 2026 ↗ |
| Virtus Westchester Credit Event Fund Virtus Event Opportunities Trust | 6,709 | 71.5K $ | 0.09 % | 0.03 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| First Trust Merger Arbitrage Fund INVESTMENT MANAGERS SERIES TRUST II | 0.44 % | as of Jun 30, 2026 ↗ |
| The Merger Fund Merger Fund | 0.24 % | as of Jun 30, 2026 ↗ |
| Virtus Westchester Credit Event Fund Virtus Event Opportunities Trust | 0.09 % | as of Jun 30, 2026 ↗ |
| First Trust Multi-Strategy Fund INVESTMENT MANAGERS SERIES TRUST II | 0.08 % | as of Jun 30, 2026 ↗ |
| JNL Multi-Manager Alternative Fund JNL Series Trust | 0.01 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 6 | 0 | 1,424,512 | -63.9 % |
| 2026Q2 | 6 | 0 | 3,943,843 | 0.0 % |
| 2026Q1 | 6 | -1 | 3,943,843 | -1.3 % |
| 2025Q4 | 7 | 0 | 3,997,713 | -0.3 % |
| 2025Q3 | 7 | +2 | 4,010,205 | +3.3 % |
| 2025Q2 | 5 | 3,883,401 |
Cite this page
Titelia. "Funds holding DRUGS MADE IN AMERICA ACQUISITION CORP". https://titelia.com/en/stocks/drugs-made-in-america-acquisition-corp-KYG2847J1040